SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-029335
Filing Date
2019-08-06
Accepted
2019-08-06 16:06:29
Documents
3
Period of Report
2019-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 Q3 2019 EARNINGS RELEASE 8-K enta-8k_20190806.htm 8-K 27403
2 EX-99.1 enta-ex991_6.htm EX-99.1 297406
3 GRAPHIC gahqe0metspq000001.jpg GRAPHIC 3526
  Complete submission text file 0001564590-19-029335.txt   330917
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35839 | Film No.: 191002093
SIC: 2834 Pharmaceutical Preparations